Quality of Life in Patients with Skull Base Tumors: Current Status and Future Challenges

 

 Buy Article Permissions and Reprints

ABSTRACT

In selection of the right treatment for a specific patient, the surgeon should consider not only the best approach to remove a tumor but also the impact of treatment on the quality of life (QOL) of the patient. Procedures involving extirpation of skull base tumors may be associated with high morbidity. It is therefore important to study patients with skull base neoplasms, because survival differences between various treatment modalities may be small, yet larger differences are expected regarding morbidity. The overall QOL in the majority of patients after skull base tumor resection can be classified as “good,” with significant improvement taking place within 12 months following surgery. Patients with carcinomas, acoustic schwannoma, or Cushing's disease suffer from more significant deterioration in their QOL after any intervention. Data retrieved from disease-specific questionnaires revealed that the financial and emotional domains have the worse impact on patients QOL. Old age, malignancy, comorbidity, radiotherapy, and extensive surgery were found to be also negative prognostic factors for QOL. Pain control regimens, antidepressants, and other psychological modalities, including group support, can improve QOL measures in these patients. It is critical that surgeons understand that they cannot assess their patients' perspectives on QOL correctly without asking them. For adequate assessment, validated disease-specific instruments addressing multiple domains of QOL should be utilized.

REFERENCES

• 1 Gil Z, Abergel A, Spektor S et al.. Quality of life following surgery for anterior skull base tumors.  Arch Otolaryngol Head Neck Surg. 2003;  129 1303-1309
  CrossrefPubMedGoogle Scholar
• 2 Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss D M. Development of a cancer-specific anterior skull base quality-of-life questionnaire.  J Neurosurg. 2004;  100 813-819
  CrossrefPubMedGoogle Scholar
• 3 Gil Z, Patel S G, Singh B International Collaborative Study Group et al. Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study.  Cancer. 2007;  110 1033-1041
  Google Scholar
• 4 Langendijk H, Aaronson N K, de Jong J M, ten Velde G P, Muller M J, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.  Radiother Oncol. 2000;  55 19-25
  PubMedGoogle Scholar
• 5 Movsas B. Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01.  Semin Radiat Oncol. 2002;  12(1, Suppl 1) 40-45
  PubMedGoogle Scholar
• 6 Sanda M G, Dunn R L, Michalski J et al.. Quality of life and satisfaction with outcome among prostate-cancer survivors.  N Engl J Med. 2008;  358 1250-1261
  CrossrefPubMedGoogle Scholar
• 7 Fliss D M, Abergel A, Cavel O, Margalit N, Gil Z. Combined subcranial approaches for excision of complex anterior skull base tumors.  Arch Otolaryngol Head Neck Surg. 2007;  133 888-896
  CrossrefPubMedGoogle Scholar
• 8 Janecka I P, Sen C, Sekhar L N et al.. Cranial base surgery: results in 183 patients.  Otolaryngol Head Neck Surg. 1994;  110 539-546
  CrossrefPubMedGoogle Scholar
• 9 Gil Z, Abergel A, Spektor S, Khafif A, Fliss D M. Patient, caregiver, and surgeon perceptions of quality of life following anterior skull base surgery.  Arch Otolaryngol Head Neck Surg. 2004;  130 1276-1281
  CrossrefPubMedGoogle Scholar
• 10 Fukuda K, Saeki N, Mine S et al.. Evaluation of outcome and QOL in patients with craniofacial resection for malignant tumors involving the anterior skull base.  Neurol Res. 2000;  22 545-550
  CrossrefPubMedGoogle Scholar
• 11 Hahn C A, Dunn R H, Logue P E, King J H, Edwards C L, Halperin E C. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors.  Int J Radiat Oncol Biol Phys. 2003;  55 992-999
  CrossrefPubMedGoogle Scholar
• 12 Martinez-Devesa P, Barnes M L, Alcock C J, Kerr R S, Milford C A. Evaluation of quality of life and psychiatric morbidity in patients with malignant tumours of the skull base.  J Laryngol Otol. 2006;  120 1049-1054
  PubMedGoogle Scholar
• 13 Mohsenipour I, Deusch E, Gabl M, Hofer M, Twerdy K. Quality of life in patients after meningioma resection.  Acta Neurochir (Wien). 2001;  143 547-553
  CrossrefPubMedGoogle Scholar
• 14 De Jesús O, Sekhar L N, Parikh H K, Wright D C, Wagner D P. Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life.  Neurosurgery. 1996;  39 915-919 discussion 919-920
  CrossrefPubMedGoogle Scholar
• 15 Lang D A, Neil-Dwyer G, Garfield J. Outcome after complex neurosurgery: the caregiver's burden is forgotten.  J Neurosurg. 1999;  91 359-363
  CrossrefPubMedGoogle Scholar
• 16 Nikolopoulos T P, Johnson I, O'Donoghue G M. Quality of life after acoustic neuroma surgery.  Laryngoscope. 1998;  108 1382-1385
  CrossrefPubMedGoogle Scholar
• 17 Tufarelli D, Meli A, Alesii A et al.. Quality of life after acoustic neuroma surgery.  Otol Neurotol. 2006;  27 403-409
  CrossrefPubMedGoogle Scholar
• 18 da Cruz M J, Moffat D A, Hardy D G. Postoperative quality of life in vestibular schwannoma patients measured by the SF36 Health Questionnaire.  Laryngoscope. 2000;  110 151-155
  CrossrefPubMedGoogle Scholar
• 19 Baumann I, Polligkeit J, Blumenstock G, Mauz P S, Zalaman I M, Maassen M M. Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach.  Acta Otolaryngol. 2005;  125 585-591
  PubMedGoogle Scholar
• 20 Irving R M, Beynon G J, Viani L, Hardy D G, Baguley D M, Moffat D A. The patient's perspective after vestibular schwannoma removal: quality of life and implications for management.  Am J Otol. 1995;  16 331-337
  CrossrefPubMedGoogle Scholar
• 21 Myrseth E, Møller P, Pedersen P H, Vassbotn F S, Wentzel-Larsen T, Lund-Johansen M. Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery.  Neurosurgery. 2005;  56 927-935 discussion 927-935
  PubMedGoogle Scholar
• 22 Sandooram D, Grunfeld E A, McKinney C, Gleeson M J. Quality of life following microsurgery, radiosurgery and conservative management for unilateral vestibular schwannoma.  Clin Otolaryngol Allied Sci. 2004;  29 621-627
  CrossrefPubMedGoogle Scholar
• 23 Ryzenman J M, Pensak M L, Tew Jr J M. Headache: a quality of life analysis in a cohort of 1,657 patients undergoing acoustic neuroma surgery, results from the acoustic neuroma association.  Laryngoscope. 2005;  115 703-711
  CrossrefPubMedGoogle Scholar
• 24 Betchen S A, Walsh J, Post K D. Self-assessed quality of life after acoustic neuroma surgery.  J Neurosurg. 2003;  99 818-823
  CrossrefPubMedGoogle Scholar
• 25 Briner H R, Linder T E, Pauw B, Fisch U. Long-term results of surgery for temporal bone paragangliomas.  Laryngoscope. 1999;  109 577-583
  CrossrefPubMedGoogle Scholar
• 26 Bülow B, Hagmar L, Ørbaek P, Osterberg K, Erfurth E M. High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease.  Clin Endocrinol (Oxf). 2002;  56 183-193
  CrossrefPubMedGoogle Scholar
• 27 Page R C, Hammersley M S, Burke C W, Wass J A. An account of the quality of life of patients after treatment for non-functioning pituitary tumours.  Clin Endocrinol (Oxf). 1997;  46 401-406
  CrossrefPubMedGoogle Scholar
• 28 Grattan-Smith P J, Morris J G, Shores E A, Batchelor J, Sparks R S. Neuropsychological abnormalities in patients with pituitary tumours.  Acta Neurol Scand. 1992;  86 626-631
  CrossrefPubMedGoogle Scholar
• 29 Peace K A, Orme S M, Padayatty S J, Godfrey H P, Belchetz P E. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication.  Clin Endocrinol (Oxf). 1998;  49 391-396
  CrossrefPubMedGoogle Scholar
• 30 Peace K A, Orme S M, Sebastian J P et al.. The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease.  Clin Endocrinol (Oxf). 1997;  46 445-450
  CrossrefPubMedGoogle Scholar
• 31 Heald A H, Ghosh S, Bray S et al.. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease.  Clin Endocrinol (Oxf). 2004;  61 458-465
  CrossrefPubMedGoogle Scholar
• 32 Lindsay J R, Nansel T, Baid S, Gumowski J, Nieman L K. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission.  J Clin Endocrinol Metab. 2006;  91 447-453
  CrossrefPubMedGoogle Scholar
• 33 Peace K A, Orme S M, Thompson A R, Padayatty S, Ellis A W, Belchetz P E. Cognitive dysfunction in patients treated for pituitary tumours.  J Clin Exp Neuropsychol. 1997;  19 1-6
  CrossrefPubMedGoogle Scholar
• 34 Noad R, Narayanan K R, Howlett T, Lincoln N B, Page R C. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life.  Clin Oncol (R Coll Radiol). 2004;  16 233-237
  CrossrefPubMedGoogle Scholar
• 35 van Beek A P, van den Bergh A C, van den Berg L M et al.. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma.  Int J Radiat Oncol Biol Phys. 2007;  68 986-991
  PubMedGoogle Scholar
• 36 Karavitaki N, Brufani C, Warner J T et al.. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.  Clin Endocrinol (Oxf). 2005;  62 397-409
  CrossrefPubMedGoogle Scholar
• 37 Kendall-Taylor P, Jönsson P J, Abs R et al.. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.  Eur J Endocrinol. 2005;  152 557-567
  CrossrefPubMedGoogle Scholar
• 38 Pereira A M, Schmid E M, Schutte P J et al.. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.  Clin Endocrinol (Oxf). 2005;  62 197-204
  CrossrefPubMedGoogle Scholar
• 39 Dekkers O M, Biermasz N R, Smit J W et al.. Quality of life in treated adult craniopharyngioma patients.  Eur J Endocrinol. 2006;  154 483-489
  CrossrefPubMedGoogle Scholar
• 40 Müller H L, Bruhnken G, Emser A et al.. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma.  Childs Nerv Syst. 2005;  21 975-980
  CrossrefPubMedGoogle Scholar
• 41 Villani R M, Tomei G, Bello L et al.. Long-term results of treatment for craniopharyngioma in children.  Childs Nerv Syst. 1997;  13 397-405
  CrossrefPubMedGoogle Scholar
• 42 Poretti A, Grotzer M A, Ribi K, Schönle E, Boltshauser E. Outcome of craniopharyngioma in children: long-term complications and quality of life.  Dev Med Child Neurol. 2004;  46 220-229
  CrossrefPubMedGoogle Scholar
• 43 Gil Z, Smith D B, Marouani N, Khafif A, Fliss D M. Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries.  Otolaryngol Head Neck Surg. 2006;  135 182-188
  CrossrefPubMedGoogle Scholar
• 44 Bardiau F M, Taviaux N F, Albert A, Boogaerts J G, Stadler M. An intervention study to enhance postoperative pain management.  Anesth Analg. 2003;  96 179-185
  CrossrefPubMedGoogle Scholar
• 45 Massie M J. Prevalence of depression in patients with cancer.  J Natl Cancer Inst Monogr. 2004;  (32) 57-71
  CrossrefPubMedGoogle Scholar
• 46 Fisch M J, Loehrer P J, Kristeller J Hoosier Oncology Group et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.  J Clin Oncol. 2003;  21 1937-1943
  CrossrefPubMedGoogle Scholar
• 47 Razavi D, Allilaire J F, Smith M et al.. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.  Acta Psychiatr Scand. 1996;  94 205-210
  CrossrefPubMedGoogle Scholar
• 48 Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review.  Br J Cancer. 2006;  94 372-390
  CrossrefPubMedGoogle Scholar
• 49 Barsevick A M, Sweeney C, Haney E, Chung E. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer.  Oncol Nurs Forum. 2002;  29 73-84 , quiz 85–87
  CrossrefPubMedGoogle Scholar
• 50 Spiegel D, Butler L D, Giese-Davis J et al.. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.  Cancer. 2007;  110 1130-1138
  Google Scholar
• 51 Fawzy F I, Fawzy N W, Hyun C S et al.. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.  Arch Gen Psychiatry. 1993;  50 681-689
  PubMedGoogle Scholar
• 52 Richardson J L, Shelton D R, Krailo M, Levine A M. The effect of compliance with treatment on survival among patients with hematologic malignancies.  J Clin Oncol. 1990;  8 356-364
  PubMedGoogle Scholar
• 53 Fliss D M, Zucker G, Cohen A et al.. Early outcome and complications of the extended subcranial approach to the anterior skull base.  Laryngoscope. 1999;  109 153-160
  CrossrefPubMedGoogle Scholar
• 54 Winzelberg A J, Classen C, Alpers G W et al.. Evaluation of an internet support group for women with primary breast cancer.  Cancer. 2003;  97 1164-1173
  CrossrefPubMedGoogle Scholar

Ziv GilM.D. Ph.D. 

Skull Base Surgery Service, Department of Otolaryngology–Head and Neck Surgery, Tel-Aviv Sourasky Medical Center

6 Weizman Street, Tel Aviv 64239, Israel

Email: ziv@baseofskull.org